Professor Trevor Laird
http://www.scientificupdate.co.uk

Trevor Laird is an international consultant and expert witness. He has many years experience in industry including ICI Corporate Laboratory, ICI Organics, and then SmithKline & French, Tonbridge (now part of GlaxoSmithKline) where he was eventually in charge of Process Development, being responsible for the design, development and scale-up of processes for manufacture. He set up Scientific Update in 1989 to provide continuing education and training, conference organisation and consultancy, particularly in his prime interest field of process chemical research and development. In addition he is the author of numerous articles and book chapters and was the prime instigator of the journal Organic Process Research and Development launched in 1997 for which he is the Editor-in-Chief. Through his company he has developed major international conferences in process chemistry, crystallisation and polymorphism, automation, chromatography and related fields. He has also developed a portfolio of training courses for chemists working in industry, covering chemical development and scale-up, crystallisation and polymorphism, good manufacturing practice, design of experiments, thermal hazards, patents in chemistry, medicinal chemistry, organic synthesis (methods and strategy), chemical engineering, kinetics and other topics. He is an internationally recognised expert and acts as a consultant to numerous pharmaceutical and chemical companies across the world. He has been involved as an expert witness in numerous trials in cases involving process chemistry, crystallisation and polymorphism and related issues. In 2003, he was appointed visiting professor at Sussex University

Professor Tim Mason
www.corporate.coventry.ac.uk

Tim Mason is Professor of Chemistry in the Faculty of Health and Life Sciences at the University of Coventry, UK. He teaches chemistry and sonochemistry at both undergraduate and postgraduate level. His main research area is in sonochemistry, the   uses of sound   energy to influence chemical reactions   and processing . In addition he is the author of more than 250 refereed journal articles, has published 13 books on sonochemistry and contributed some 20 chapters in other texts. He is currently the Editor in Chief of Ultrasonics Sonochemistry, President of the European Sonochemical Society and Chairman of the Royal Society of Chemistry Sonochemistry Group. He has given 30 plenary lectures in the last five years and is the Director of the Centre for Sonochemistry at Coventry University .

Mr John Perkins
www.sonicsystems.co.uk/

John Perkins is the founder, co-owner and Managing Director of Sonic Systems Ltd. He has over 40 years experience in the science of ultrasound and building of ultrasonic devices for a variety of industries. He is the inventor of the Prosonitron flow-cell and his name is on the key patent relating to this.

Dr Robert Price
people.bath.ac.uk/prsrp/
www.bath.ac.uk/pharmacy/home/index.shtml

Rob Price is a senior lecturer in pharmaceutical technology in the 5* RAE rated Department of Pharmacy and Pharmacology at the University of Bath where he leads the pharmaceutical technology research group.   His main research interests are pharmaceutical surface science and particle engineering.   A key area of work is focussed on investigating the physicochemical properties that govern inter-particulate adhesion, issues relating to the surface stability of processed particles and the general areas of particle technology and crystal growth.   He has extensive contact with large pharmaceutical organisations as well as close involvement with small innovator pharmaceutical companies.

Professor Kevin Roberts
www.leeds.ac.uk/chemeng/STAFF/Roberts/roberts-full.html www.leeds.ac.uk/speme/ipse/contacts-frame.html
www.leeds.ac.uk/chemeng/CBB/cbb2.html
www.leeds.ac.uk/chemeng/pharmeng/index.html

Kevin Roberts is Brotherton Professor of Chemical Engineering in the Institute of Particle Science and Engineering and Director of Research for the School of Process, Environmental and Materials Engineering at the University of Leeds in the UK. His research centres in the area of crystal science and engineering directed to meet the needs of the pharmaceuticals, nuclear, specialities, fine chemicals, and nutritional products sectors. Particular areas for current focus include: molecular solid-state chemistry, industrial crystallisation, nano-scale engineering using molecular modelling, use of synchrotron radiation techniques, process analytical techniques (PAT) for reactor monitoring and control, multi-scale computational modelling, scale-up of process from laboratory to manufacturing.

Dr Peter Spargo
www.scientificupdate.co.uk

Pete Spargo accumulated over 15-years experience in pharmaceutical R&D whilst associated with Pfizer. He ultimately became Head of Pfizer's European Chemical Research and Development Department with responsibility for directing some 170 Pfizer Chemical Research and Development staff at three European sites, and with significant multi-disciplinary project management responsibility.   He joined Scientific Update in September 2003 and became Managing Director in January 2006. In this role he has significant responsibility for consultancy, conferences and training courses. He acts as an international consultant to a number of pharmaceutical companies and also as an expert witness in patent litigation. In addition to teaching the Chemical Development course, he has also developed new courses in Green Chemistry and Microwave Chemistry.

Dr George E Tranter
www.cie.ox.ac.uk

George Tranter is an acknowledged expert in medicinal chemistry, circular dichroism, crystallization and protein structure and director of Chiralabs Ltd (UK).   In addition he is former Principal Research Fellow in BioSpectroscopy, Division of Biomedical Sciences and Medicine, Imperial College, London.   One particular interest is in the determination of three dimensional protein structure and interactions under realistic industrial or natural conditions. He left Imperial College in 2006 to concentrate on the development of Chiralabs following relocation to Oxford.

Dr Will Watson
www.scientificupdate.co.uk

Will Watson has extensive experience in industry including BP Research Centre at Sunbury-on-Thames and Lancaster Synthesis where he was responsible for laboratory scale production and process research and development to support Lancaster's catalogue, semi-bulk and custom synthesis businesses. In 1993 he was appointed to the position of Technical Director, responsible for all Production, Process Research and Development, Engineering and Quality Control. He helped set up and run the Lancaster Laboratories near Chennai, India and had technical responsibility for the former PCR laboratories at Gainesville, Florida. He joined Scientific Update as Technical Director in May 2000. He has revised and rewritten the 'Chemical Development and Scale Up in the Fine Chemical & Pharmaceutical Industries' course and gives this course regularly around the world. He has been instrumental in setting up and developing many new courses. He is also involved in an advisory capacity in setting up conferences and in the running of the events. He is active in the consultancy side of the business and sits on the Scientific Advisory Boards of various companies.